USD 5.84
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 635.71 Million USD | 5.53% |
2022 | 602.4 Million USD | 4.85% |
2021 | 574.54 Million USD | -27.22% |
2020 | 789.42 Million USD | 68.09% |
2019 | 469.64 Million USD | 1.41% |
2018 | 463.11 Million USD | 2.0% |
2017 | 454.05 Million USD | 5.45% |
2016 | 430.58 Million USD | 47.87% |
2015 | 291.18 Million USD | 43.8% |
2014 | 202.49 Million USD | 168.52% |
2013 | 75.41 Million USD | 53.55% |
2012 | 49.11 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 596.05 Million USD | -6.24% |
2024 Q2 | 603.33 Million USD | 1.22% |
2023 Q1 | 574.42 Million USD | -4.65% |
2023 FY | 635.71 Million USD | 5.53% |
2023 Q3 | 561.58 Million USD | -1.39% |
2023 Q2 | 569.51 Million USD | -0.85% |
2023 Q4 | 635.71 Million USD | 13.2% |
2022 Q1 | 532.87 Million USD | -7.25% |
2022 Q2 | 523.91 Million USD | -1.68% |
2022 Q3 | 605.51 Million USD | 15.57% |
2022 Q4 | 602.4 Million USD | -0.51% |
2022 FY | 602.4 Million USD | 4.85% |
2021 Q2 | 599.54 Million USD | -22.71% |
2021 Q3 | 582.42 Million USD | -2.85% |
2021 Q4 | 574.54 Million USD | -1.35% |
2021 Q1 | 775.67 Million USD | -1.74% |
2021 FY | 574.54 Million USD | -27.22% |
2020 FY | 789.42 Million USD | 68.09% |
2020 Q3 | 778.44 Million USD | 3.36% |
2020 Q1 | 459.96 Million USD | -2.06% |
2020 Q4 | 789.42 Million USD | 1.41% |
2020 Q2 | 753.17 Million USD | 63.75% |
2019 FY | 469.64 Million USD | 1.41% |
2019 Q2 | 447.99 Million USD | -2.21% |
2019 Q3 | 447.73 Million USD | -0.06% |
2019 Q1 | 458.11 Million USD | -1.08% |
2019 Q4 | 469.64 Million USD | 4.89% |
2018 Q1 | 444.84 Million USD | -2.03% |
2018 Q3 | 451.05 Million USD | 0.26% |
2018 Q4 | 463.11 Million USD | 2.68% |
2018 FY | 463.11 Million USD | 2.0% |
2018 Q2 | 449.88 Million USD | 1.13% |
2017 Q2 | 420.77 Million USD | 0.7% |
2017 FY | 454.05 Million USD | 5.45% |
2017 Q4 | 454.05 Million USD | 3.68% |
2017 Q3 | 437.93 Million USD | 4.08% |
2017 Q1 | 417.86 Million USD | -2.95% |
2016 Q4 | 430.58 Million USD | 2.55% |
2016 Q1 | 274.45 Million USD | -5.75% |
2016 FY | 430.58 Million USD | 47.87% |
2016 Q2 | 412.31 Million USD | 50.23% |
2016 Q3 | 419.86 Million USD | 1.83% |
2015 Q1 | 192.22 Million USD | -5.07% |
2015 FY | 291.18 Million USD | 43.8% |
2015 Q2 | 297.32 Million USD | 54.68% |
2015 Q4 | 291.18 Million USD | 1.22% |
2015 Q3 | 287.68 Million USD | -3.24% |
2014 Q2 | 62.9 Million USD | -7.38% |
2014 Q1 | 67.91 Million USD | -9.94% |
2014 Q3 | 56.11 Million USD | -10.8% |
2014 Q4 | 202.49 Million USD | 260.87% |
2014 FY | 202.49 Million USD | 168.52% |
2013 FY | 75.41 Million USD | 53.55% |
2013 Q4 | 75.41 Million USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 FY | 49.11 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Abbott Laboratories | 73.21 Billion USD | 99.132% |
Allurion Technologies Inc. | 71.71 Million USD | -786.481% |
Artivion, Inc. | 792.39 Million USD | 19.773% |
Avanos Medical, Inc. | 1.69 Billion USD | 62.437% |
Butterfly Network, Inc. | 304.27 Million USD | -108.928% |
Butterfly Network, Inc. | 304.27 Million USD | -108.928% |
Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 94.831% |
Boston Scientific Corporation | 35.13 Billion USD | 98.191% |
CONMED Corporation | 2.3 Billion USD | 72.361% |
Edwards Lifesciences Corporation | 9.36 Billion USD | 93.211% |
Paragon 28, Inc. | 340.69 Million USD | -86.591% |
Glaukos Corporation | 940.41 Million USD | 32.401% |
Globus Medical, Inc. | 5.08 Billion USD | 87.501% |
Inspire Medical Systems, Inc. | 676.81 Million USD | 6.072% |
Integer Holdings Corporation | 2.94 Billion USD | 78.397% |
Medtronic plc | 89.98 Billion USD | 99.294% |
Myomo, Inc. | 14.58 Million USD | -4259.703% |
Owlet, Inc. | 44.12 Million USD | -1340.775% |
Penumbra, Inc. | 1.55 Billion USD | 59.152% |
Vicarious Surgical Inc. | 119.86 Million USD | -430.362% |
Smith & Nephew plc | 9.98 Billion USD | 93.635% |
Sonendo, Inc. | 78.16 Million USD | -713.348% |
STERIS plc | 11.06 Billion USD | 94.254% |
Stryker Corporation | 39.91 Billion USD | 98.407% |
Vapotherm, Inc. | 77.61 Million USD | -719.038% |
Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 97.043% |